We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors PR Newswire BOSTON, Dec. 12, 2024 -- EO-1022 is comprised of...
Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 PR...
Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire BOSTON, Nov. 26, 2024 BOSTON, Nov. 26, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq:...
Elevation Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, Nov. 6, 2024 -- Promising initial Phase 1 data of EO-3021 reported...
Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0195 | 3.30788804071 | 0.5895 | 0.6098 | 0.5451 | 873986 | 0.58139518 | CS |
4 | -0.011 | -1.77419354839 | 0.62 | 0.8099 | 0.5451 | 971314 | 0.63151897 | CS |
12 | 0.0665 | 12.2580645161 | 0.5425 | 0.8099 | 0.5 | 763778 | 0.60353724 | CS |
26 | -2.071 | -77.276119403 | 2.68 | 3.28 | 0.5 | 997556 | 1.01080548 | CS |
52 | 0.069 | 12.7777777778 | 0.54 | 5.8299 | 0.5 | 1435016 | 2.1487766 | CS |
156 | -4.911 | -88.9673913043 | 5.52 | 6.866 | 0.363 | 788576 | 2.53434443 | CS |
260 | -13.391 | -95.65 | 14 | 16.22 | 0.363 | 683696 | 2.64173199 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions